Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria — United States, 2008 and 2013

Morbidity and Mortality Weekly Report

Volumn 63, Issue 34, 2014, Pages 753-755

  Paczkowski, Magdalena M ^a   Landman, Keren L ^a   Arguin, Paul M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE;

ADULT; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; INFUSION; MALARIA FALCIPARUM; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; TIME; UNITED STATES;

ADULT; ANEMIA, HEMOLYTIC; ANTIMALARIALS; ARTEMISININS; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOLYSIS; HUMANS; INFUSIONS, PARENTERAL; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 84906854066     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Dondorp A, Nosten F, Stepniewska K, et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005;366:717-25.
2. Sinclair D, Donegan S, Isba R, et al. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev 2012;6:CD005967.
3. CDC. Malaria surveillance—United States, 2011. MMWR 2013;62 (No. SS-5).
4. CDC. Treatment with quinidine gluconate of persons with severe plasmodium falciparum infection: discontinuation of parenteral quinine. MMWR 1991;40(No. RR-4):21-3.
5. CDC. Notice to readers: new medication for severe malaria available under an investigational new drug protocol. MMWR 2007;56:769-70.
6. CDC. Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria—worldwide, 2010-2012. MMWR 2013;62:5-8.
7. Rolling T, Agbenyega T, Issifou S, et al. Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria—a double-center prospective study. J Infect Dis 2014;209:1921-8.
8. Jaureguiberry S, Ndour PA, Roussel C, et al. Postartesunate delayed hemolysis is a predictable event related to the livesaving effect of artemisinins. Blood 2014;124:167-75.
9. CDC. Guidelines for treatment of malaria in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://www.cdc.gov/malaria/resources/pdf/clinicalguidance.pdf.
10. Arguin P. Case definition: postartemisinin delayed hemolysis. Blood 2014;124:157-8.